sense to me. If it was good before it's maybe better now.
Illumina develops sequencing and array-based technologies for genetic and genomic analysis across global markets.
Could Illumina's genomic leadership position them for significant growth as geopolitical tensions ease? What's your view on the potential reunion with Grail?
https://www.theinsidersfund.com/2025/05/insider-buying-week-05-16-25-pharma-and-life-sciences-bargain-bin/
#InsiderBuying #Genomics #NotInvestmentAdvice #ILMN #BiotechInvesting